Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Cancers|November 27, 2025
Optimal Timing of Treatment Initiation in Non-Metastatic Castration-Resistant Prostate Cancer Based on PSA Level and Doubling Time for Prognostic BenefitTakuto Ogasawara, Kohei Hashimoto, Tetsuya Shindo, et al.Clinical Case Reports|February 18, 2021
Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancerGinji Omori, Kohichi Takada, Kazuyuki Murase, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2013
Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer riskYukiko Sugiyama, Naoya Masumori, Fumimasa Fukuta, et al.International Journal of Clinical Oncology|February 14, 2013
Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatmentYuki Kyoda, Ko Kobayashi, Megumi Hirobe, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2021
Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trialYuki Kyoda, Manabu Okada, Ryuichi Kato, et al.Hinyokika Kiyo. Acta Urologica Japonica|September 22, 2009
[Factor analysis of the Japanese version of the Aging Males' Symptoms rating scale]Ko Kobayashi, Ryuichi Kato, Kohei Hashimoto, et al.International Urology and Nephrology|June 6, 2016
Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese menYoshie Nagata, Yukiko Sugiyama, Fumimasa Fukuta, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Counts of Slackia sp. strain NATTS in intestinal flora are correlated to serum concentrations of equol both in prostate cancer cases and controls in Japanese menYukiko Sugiyama, Yoshie Nagata, Fumimasa Fukuta, et al.Current Urology|August 23, 2024
Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy?Yuki Kyoda, Kohei Hashimoto, Atsushi Takahashi, et al.Japanese Journal of Clinical Oncology|April 12, 2015
Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in JapanFumimasa Fukuta, Hiroshi Kitamura, Masahiro Yanase, et al.Pageof 7